The CCPG1 Polyclonal Antibody (PACO8258) is a valuable tool for researchers studying CCPG1, a protein involved in cellular signaling pathways and potentially linked to cancer development. This antibody, generated in rabbits, exhibits high specificity and sensitivity towards CCPG1 in human samples, making it suitable for Western blot applications.CCPG1, also known as Cell Cycle Progression Gene 1, is believed to play a crucial role in cell cycle regulation and proliferation. Abnormal expression of CCPG1 has been implicated in various cancers, suggesting its potential as a diagnostic and therapeutic target.
By using the PACO8258 antibody, researchers can investigate the function and expression levels of CCPG1 in different cell types, shedding light on its involvement in cancer progression and providing insights for targeted treatment strategies.Overall, the PACO8258 antibody offers a reliable tool for studying CCPG1 in cancer biology and other related research areas, contributing to a better understanding of the mechanisms underlying malignant cell growth and offering potential avenues for therapeutic intervention.
CCPG1: Acts as an assembly platform for Rho protein signaling complexes. Limits guanine nucleotide exchange activity of MCF2L toward RHOA, which results in an inhibition of both its transcriptional activation ability and its transforming activity. Does not inhibit activity of MCF2L toward CDC42, or activity of MCF2 toward either RHOA or CDC42. May be involved in cell cycle regulation. Belongs to the CCPG1 family. 4 isoforms of the human protein are produced by alternative splicing.Protein type: Membrane protein, integralChromosomal Location of Human Ortholog: 15q21.1Cellular Component: integral to membraneBiological Process: positive regulation of cell proliferation; positive regulation of cell cycle; cell cycle
